Le Lézard
Classified in: Covid-19 virus
Subject: Lawsuit

NATIONAL VISION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against National Vision Holdings, Inc. and Encourages Investors to Contact the Firm


Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against National Vision Holdings, Inc. ("National Vision" or the "Company") (NASDAQ: EYE) in the United States District Court for the Northern District of Georgia on behalf of all persons and entities who purchased or otherwise acquired National Vision securities between May 13, 2021 and May 9, 2022, both dates inclusive (the "Class Period"). Investors have until March 28, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

According to the Complaint, the Company made false and misleading statements to the market. National Vision faced considerable wage and hiring pressure due to competition and other factors including the COVID-19 pandemic. The Company launched a multi-million-dollar retention plan to avoid mass resignations in 2021. This retention plan was likely to negatively impact the Company's financial performance in the fourth quarter to a greater extent than it informed investors. Despite the retention plan, the Company faced a startling shortage of optometrists in 2022. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about National Vision, investors suffered damages.

If you purchased or otherwise acquired National Vision shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.


These press releases may also interest you

at 15:50
Cue Health , a healthcare technology company, announces an industry breakthrough as the first company to receive De Novo authorization from the U.S. Food and Drug Administration (FDA) for its Cue COVID-19 Molecular Test, designed for both home and...

at 15:49
Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus...

at 15:35
Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas' LNP technology will support Bayer's in vivo gene...

at 14:45
The "Dental Floss Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War" report has been added to ResearchAndMarkets.com's offering. The global dental floss market is...

at 14:38
Texas Children's Hospital is pleased to announce that Dr. Maria Elena Bottazzi, Co-Director of the Center for Vaccine Development at Texas Children's Hospital and Senior Associate Dean of the National School of Tropical Medicine at Baylor College of...

at 14:30
The "Financial Advisory Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market.The global...



News published on and distributed by: